Nur Nicholson - 13 Jan 2026 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Technical Officer
Signature
/s/ David Watson, attorney-in-fact for Nur Nicholson
Issuer symbol
APLS
Transactions as of
13 Jan 2026
Net transactions value
-$58,086
Form type
4
Filing time
15 Jan 2026, 16:30:08 UTC
Previous filing
11 Jun 2025
Next filing
21 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nicholson Nur Chief Technical Officer C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM /s/ David Watson, attorney-in-fact for Nur Nicholson 15 Jan 2026 0001827317

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $58,086 -2,618 -3.1% $22.19 81,046 13 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 12, 2026.